loading

Corcept Therapeutics Inc (CORT) 最新ニュース

pulisher
08:18 AM

Diabetes Care Publishes Results From Prevalence Phase Of Corcept's CATALYST Trial In People With Difficult-To-Control Type 2 Diabetes | CORT Stock News - GuruFocus

08:18 AM
pulisher
08:17 AM

Diabetes Care Publishes Results From Prevalence Phase Of Corcept'S CATALYST Trial In People With Difficult-To-Control Type 2 Diabetes - marketscreener.com

08:17 AM
pulisher
08:00 AM

Landmark 1,000-Patient Diabetes Study Reveals Surprising Link to Cushing's Syndrome in Treatment-Resistant Cases - Stock Titan

08:00 AM
pulisher
Apr 16, 2025

SoundHound AI, Domo, Plug Power, Corcept, and 8x8 Shares Are Falling, What You Need To Know - Barchart.com

Apr 16, 2025
pulisher
Apr 16, 2025

$1000 Invested In Corcept Therapeutics 20 Years Ago Would Be Worth This Much Today - Benzinga

Apr 16, 2025
pulisher
Apr 15, 2025

It's Still Early For Corcept: With Multiple Growth Opportunities Ahead, It's No Longer Just A One Drug Wonder - Seeking Alpha

Apr 15, 2025
pulisher
Apr 14, 2025

Corcept therapeutics director Daniel Swisher sells stock for $154,484 By Investing.com - Investing.com Canada

Apr 14, 2025
pulisher
Apr 14, 2025

Corcept therapeutics director Daniel Swisher sells stock for $154,484 - Investing.com

Apr 14, 2025
pulisher
Apr 09, 2025

Corcept Therapeutics (NasdaqCM:CORT) Rises 36% in Last Quarter - Yahoo

Apr 09, 2025
pulisher
Apr 07, 2025

Corcept Initiates Trial Of Relacorilant Plus NAB-Paclitaxel And Bevacizumab - MarketScreener

Apr 07, 2025
pulisher
Apr 07, 2025

Corcept Initiates Trial of Relacorilant Plus Nab-Paclitaxel and Bevacizumab in Patients With Platinum-Resistant Ovarian Cancer - Business Wire

Apr 07, 2025
pulisher
Apr 07, 2025

Breakthrough Ovarian Cancer Trial Combines Three Powerful Treatments in Phase 2 Study - Stock Titan

Apr 07, 2025
pulisher
Apr 06, 2025

How Some Mid Cap Stocks Outshone The S&P 400's Dramatic Drop Last Week (Mar 31-Apr 4) - Benzinga

Apr 06, 2025
pulisher
Apr 05, 2025

Corcept Therapeutics (NASDAQ:CORT) Stock Price Expected to Rise, Piper Sandler Analyst Says - Defense World

Apr 05, 2025
pulisher
Apr 04, 2025

Corcept Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:CORT - Benzinga

Apr 04, 2025
pulisher
Apr 04, 2025

Commonwealth Equity Services LLC Has $700,000 Position in Corcept Therapeutics Incorporated (NASDAQ:CORT) - Defense World

Apr 04, 2025
pulisher
Apr 04, 2025

What is HC Wainwright’s Estimate for CORT FY2026 Earnings? - Defense World

Apr 04, 2025
pulisher
Apr 03, 2025

Corcept therapeutics officer sells $20.2 million in stock By Investing.com - Investing.com Australia

Apr 03, 2025
pulisher
Apr 03, 2025

Piper Sandler lifts Corcept stock target to $131 post-study By Investing.com - Investing.com UK

Apr 03, 2025
pulisher
Apr 03, 2025

Corcept Therapeutics’ chief development officer sells $77,639 in stock By Investing.com - Investing.com India

Apr 03, 2025
pulisher
Apr 03, 2025

Corcept therapeutics CEO Joseph Belanoff sells $3.37 million in shares By Investing.com - Investing.com Canada

Apr 03, 2025
pulisher
Apr 02, 2025

Corcept therapeutics CEO Joseph Belanoff sells $3.37 million in shares - Investing.com Australia

Apr 02, 2025
pulisher
Apr 02, 2025

Corcept therapeutics president sells shares worth $10.1 million By Investing.com - Investing.com Canada

Apr 02, 2025
pulisher
Apr 02, 2025

Corcept Therapeutics’ chief development officer sells $77,639 in stock - Investing.com

Apr 02, 2025
pulisher
Apr 02, 2025

Corcept therapeutics president sells shares worth $10.1 million - Investing.com

Apr 02, 2025
pulisher
Apr 02, 2025

Corcept therapeutics officer sells $20.2 million in stock - Investing.com

Apr 02, 2025
pulisher
Apr 02, 2025

Corcept Therapeutics Stock (CORT) Rockets Up 100% After Groundbreaking Cancer Trial Success - markets.businessinsider.com

Apr 02, 2025
pulisher
Apr 02, 2025

Does Corcept (CORT) Have the Potential to Rally 28.63% as Wall Street Analysts Expect? - Yahoo Finance

Apr 02, 2025
pulisher
Apr 02, 2025

Corient Private Wealth LLC Purchases New Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT) - Defense World

Apr 02, 2025
pulisher
Apr 02, 2025

Corcept Therapeutics (NASDAQ:CORT) Given New $142.00 Price Target at Canaccord Genuity Group - Defense World

Apr 02, 2025
pulisher
Apr 02, 2025

Corcept's ovarian cancer drug meets main goal in late-stage study, shares jump - MSN

Apr 02, 2025
pulisher
Apr 01, 2025

Corcept Therapeutics stock target raised to $150 by H.C. Wainwright - Investing.com Canada

Apr 01, 2025
pulisher
Apr 01, 2025

Corcept Therapeutics (CORT) Stock Surges Following Positive Tria - GuruFocus

Apr 01, 2025
pulisher
Apr 01, 2025

Corcept Therapeutics (CORT) Surges 109% Following Positive Trial Results - GuruFocus

Apr 01, 2025
pulisher
Apr 01, 2025

U.S. Markets Ended Tuesday Mixed As monday.com Led, Corcept Therapeutics Lagged - Barron's

Apr 01, 2025
pulisher
Apr 01, 2025

Yum Brands (YUM) Seeks New CEO as Corcept (CORT) and Hut 8 (HUT) Shares Climb - GuruFocus

Apr 01, 2025
pulisher
Apr 01, 2025

Corcept Therapeutics Unusual Options Activity For April 01 - Benzinga

Apr 01, 2025
pulisher
Apr 01, 2025

Daily Digest: State Farm's newest rate hike request; Stock soars on cancer results - The Business Journals

Apr 01, 2025
pulisher
Apr 01, 2025

CORT Shares Rise as Relacorilant Combo Meets Ovarian Cancer Study Goal - TradingView

Apr 01, 2025
pulisher
Apr 01, 2025

Corcept's relacorilant trial in patients with platinum-resistant ovarian cancer meets primary endpoint - Pharmafile

Apr 01, 2025
pulisher
Apr 01, 2025

Corcept (CORT) Stock Jumps 109.1%: Will It Continue to Soar? - Nasdaq

Apr 01, 2025
pulisher
Apr 01, 2025

Truist Securities lifts Corcept Therapeutics target to $150 - Investing.com

Apr 01, 2025
pulisher
Apr 01, 2025

Here's Why Momentum in Corcept (CORT) Should Keep going - Yahoo Finance

Apr 01, 2025
pulisher
Apr 01, 2025

Corcept Therapeutics: The ROSELLA Trial Presents A Major Win For The Company - Seeking Alpha

Apr 01, 2025
pulisher
Apr 01, 2025

Why Corcept Therapeutics Incorporated (CORT) Went Up On Monday? - Yahoo

Apr 01, 2025
pulisher
Apr 01, 2025

Corcept Therapeutics Reaches Analyst Target Price - Nasdaq

Apr 01, 2025
pulisher
Apr 01, 2025

Corcept Therapeutics Shares Surge 109% to $114.22 on Phase 3 Trial Breakthrough - TradingPedia

Apr 01, 2025
pulisher
Apr 01, 2025

Corcept’s Phase III trial of ovarian cancer therapy shows PFS improvement - Yahoo Finance

Apr 01, 2025
pulisher
Apr 01, 2025

HC Wainwright Issues Positive Forecast for Corcept Therapeutics (NASDAQ:CORT) Stock Price - Defense World

Apr 01, 2025
pulisher
Apr 01, 2025

AIG, Corcept Therapeutics, Dow - TradingView

Apr 01, 2025
pulisher
Apr 01, 2025

Truist Financial Issues Positive Forecast for Corcept Therapeutics (NASDAQ:CORT) Stock Price - Defense World

Apr 01, 2025
pulisher
Apr 01, 2025

Corcept Therapeutics (NASDAQ:CORT) Shares Gap Up After Analyst Upgrade - Defense World

Apr 01, 2025
pulisher
Mar 31, 2025

Why Corcept Therapeutics (CORT) Stock Skyrocketed Today - GuruFocus

Mar 31, 2025
pulisher
Mar 31, 2025

Corcept Therapeutics (CORT) Shares Skyrocket Amid Clinical Trial Success - GuruFocus

Mar 31, 2025
pulisher
Mar 31, 2025

Corcept Therapeutics shares double on solid Phase 3 results for ovarian cancer treatment - Mugglehead Magazine

Mar 31, 2025
pulisher
Mar 31, 2025

Corcept Therapeutics stock soars to all-time high of $95.42 By Investing.com - Investing.com South Africa

Mar 31, 2025
pulisher
Mar 31, 2025

Corcept looks to NDA following strong phase III ovarian cancer data - BioWorld MedTech

Mar 31, 2025
pulisher
Mar 31, 2025

Corcept’s Relacorilant Shows Benefit In Ovarian Cancer, Expanding Pipeline Opportunity - insights.citeline.com

Mar 31, 2025
pulisher
Mar 31, 2025

Corcept Therapeutics’ Unexpected Performance: Should Investors Keep Watch? - timothysykes.com

Mar 31, 2025
pulisher
Mar 31, 2025

Corcept (CORT) Shares Soar 95% on Positive Phase 3 Trial Results - GuruFocus

Mar 31, 2025
$19.85
price down icon 0.77%
$71.22
price down icon 2.53%
$32.51
price up icon 0.11%
$24.83
price down icon 0.47%
$97.38
price down icon 1.48%
biotechnology ONC
$231.14
price up icon 0.63%
大文字化:     |  ボリューム (24 時間):